US Digital Health Market Insights & Forecast 2024-2028, with Profiles of Leading Players Apple, McKesson, Alphabet, Cisco Systems, Cerner and Allscripts Healthcare Solutions – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “US Digital Health Market (by Technology & Component): Insights & Forecast (2024-2028)” report has been added to ResearchAndMarkets.com’s offering.


The U.S. digital health market is predicted to reach US$396.75 billion in 2028, progressing at a CAGR of 28.4%, over the period 2024-2028.

The factors such as increasing geriatric population, growing usage of mobile devices, surging prevalence of arthritis, hike in healthcare expenditure, expanding urbanization and mounting penetration of internet users would drive the growth of the market. However, the market growth would be challenged by high capital cost and installations, lack of interoperability and data breach and security concerns. A few notable trends include upsurge in the number of healthcare apps, surging occurrence of chronic diseases, escalating penetration of electronic health record (EHR) systems and increasing importance of wearable devices.

The U.S. digital health market has been segmented on the basis of technology and component. In terms of technology, the U.S. digital health market can be bifurcated into mHealth, digital health systems, health analytics and tele healthcare. Whereas, the market can be split into services, hardware and software, on the basis of component.

The mHealth segment is the fastest growing market, owing to rapid digitalization, mounting occurrence of chronic diseases such as cardiovascular diseases and diabetes in the region, various technological advancements in the healthcare industry coupled with recent advancements in wearable technologies and high internet usage. In addition, the growing number of COVID-19 cases across the region in 2020, escalated the adoption of digital health solutions to maintain social distancing and to improve the communication between patients and healthcare professionals during the pandemic.

Scope of the report

  • The report provides a comprehensive analysis of the U.S. digital health market segmented on the basis of technology and component.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Apple Inc., McKesson Corporation, Alphabet Inc., Cisco Systems, Inc., Cerner Corporation and Allscripts Healthcare Solutions, Inc.) are also presented in detail. 

Key Attributes:

Report Attribute Details
No. of Pages 71
Forecast Period 2024 – 2028
Estimated Market Value (USD) in 2024 $145.97 Billion
Forecasted Market Value (USD) by 2028 $396.75 Billion
Compound Annual Growth Rate 28.4%
Regions Covered United States 

Key Topics Covered:

1. Market Overview

1.1 Introduction

1.2 Global Evolution of Digital Health

1.3 Classification of Digital Health

1.4 Essential Components of Digital Health

1.5 Benefits of Digital Health Technologies

1.6 Technologies Involved in Digital Healthcare

1.7 Digital Health Tools

2. Impact of COVID-19

2.1 Demand Surge for Digital Health Solutions

2.2 Surging Adoption of Telemedicine

2.3 Rising Depression Rate

3. The U.S. Market Analysis

3.1 The U.S. Digital Health Market by Value

3.2 The U.S. Digital Health Market Forecast by Value

3.3 The U.S. Digital Health Market by Technology

3.4 The U.S. Digital Health Market by Component

4. Market Dynamics

4.1 Growth Drivers

4.1.1 Increasing Geriatric Population

4.1.2 Growing Usage of Mobile Devices

4.1.3 Surging Prevalence of Arthritis

4.1.4 Hike in Healthcare Expenditure

4.1.5 Expanding Urbanization

4.1.6 Surging Occurrence of Chronic Diseases

4.1.7 Mounting Penetration of Internet Users

4.2 Key Trends & Developments

4.2.1 Upsurge in the Number of Healthcare Apps

4.2.2 Escalating Penetration of Electronic Health Record (EHR) Systems

4.2.3 Increasing Importance of Wearable Devices

4.2.4 Rising Integration with Artificial Intelligence

4.2.5 Surging Adoption of SaaS Applications

4.2.6 Supportive Government Initiatives

4.3 Challenges

4.3.1 High Capital Cost and Installations

4.3.2 Lack of Interoperability

4.3.3 Data Breach and Security Concerns

5. Company Profiles

  • Allscripts Healthcare Solutions, Inc.
  • Alphabet Inc.
  • Apple Inc.
  • Cerner Corporation
  • Cisco Systems, Inc.
  • McKesson Corporation

For more information about this report visit https://www.researchandmarkets.com/r/p2ogzg

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Staff

Recent Posts

Masimo Shares Final Thoughts Ahead of September 19 Annual Meeting Where Everything is at Stake

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive…

3 hours ago

Investigational Rinatabart Sesutecan (Rina-S) Shows Promising Anti-Tumor Activity as Single Agent in Heavily Pretreated Patients with Ovarian and Endometrial Cancers in Phase 1/2 Clinical Trial

Media ReleaseCOPENHAGEN, Denmark; September 15, 2024 Treatment with rinatabart sesutecan (Rina-S) showed encouraging response rate…

18 hours ago

Ipsen provides update on CONTACT-02 Phase III trial in metastatic castration-resistant prostate cancer following final overall survival analysis

Trial investigating Cabometyx® (cabozantinib) in combination with atezolizumab demonstrated a positive trend towards improvement for…

18 hours ago

KFSHRC Leads as a Premier Destination for Medical Tourism and Innovative Care Solutions

RIYADH, Saudi Arabia, Sept. 15, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research…

18 hours ago

Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging

Prostate-specific membrane antigen (PSMA) is a leading target for next-generation prostate cancer therapies, with one…

18 hours ago

23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 Study

23ME-00610 monotherapy demonstrates preliminary evidence of clinical benefit in clear-cell renal-cell carcinoma, with one confirmed…

18 hours ago